Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
暂无分享,去创建一个
G. Pruneri | A. Vingiani | M. Daidone | S. Calza | C. Klein | V. Cappelletti | B. Polzer | M. Silvestri | C. Ferraris | Giancarlo Feliciello | T. Schamberger | C. Köstler | C. Reduzzi | R. Motta | M. Vismara
[1] G. Pruneri,et al. Dissemination of Circulating Tumor Cell Clusters Occurs Early in Non‑metastatic Breast Cancer Patients , 2021 .
[2] R. Piñeiro,et al. Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes , 2020, Cancers.
[3] N. Aceto. Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis , 2020, Biomedical journal.
[4] Crispin J. Miller,et al. Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] M. Daidone,et al. A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer , 2019, International journal of cancer.
[6] Ahmedin Jemal,et al. Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[7] G. Hortobagyi,et al. Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study , 2019, Clinical Cancer Research.
[8] T. Oliver,et al. Partners in Crime: Neutrophil-CTC Collusion in Metastasis. , 2019, Trends in immunology.
[9] P. Hofman,et al. Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment , 2019, Cells.
[10] P. Jia,et al. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling , 2019, International journal of molecular sciences.
[11] N. Beerenwinkel,et al. Neutrophils escort circulating tumour cells to enable cell cycle progression , 2019, Nature.
[12] S. Haferkamp,et al. Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samples , 2019, International journal of cancer.
[13] J. C. Love,et al. Tumor fraction in cell-free DNA as a biomarker in prostate cancer. , 2018, JCI insight.
[14] Pingzhao Hu,et al. Association Analysis of Somatic Copy Number Alteration Burden With Breast Cancer Survival , 2018, Front. Genet..
[15] N. Loman,et al. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial , 2018, Breast Cancer Research.
[16] Nikhil Wagle,et al. Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Nikhil Wagle,et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors , 2017, Nature Communications.
[18] Ryan E. Mills,et al. Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy , 2017, Oncotarget.
[19] M. Daidone,et al. Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods , 2017, Disease markers.
[20] Rainer Spang,et al. Early dissemination seeds metastasis in breast cancer , 2016, Nature.
[21] P. Bendahl,et al. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort , 2016, BMC Cancer.
[22] H. Morreau,et al. Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing , 2016, Scientific Reports.
[23] Yupei Zhao,et al. Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance. , 2016, Medical hypotheses.
[24] Hushan Yang,et al. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer , 2015, Breast Cancer Research and Treatment.
[25] Ana Conesa,et al. Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data , 2015, Bioinform..
[26] M. Daidone,et al. Did Circulating Tumor Cells Tell us all they Could? The Missed Circulating Tumor Cell Message in Breast Cancer , 2015, The International journal of biological markers.
[27] I. Fidler,et al. The challenge of targeting metastasis , 2015, Cancer and Metastasis Reviews.
[28] P. Neven,et al. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. , 2015, JAMA oncology.
[29] J. Garber,et al. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. , 2015, JAMA.
[30] Dafydd G. Thomas,et al. Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019 , 2015, Clinical Cancer Research.
[31] Nicolò Manaresi,et al. Molecular profiling of single circulating tumor cells with diagnostic intention , 2014, EMBO molecular medicine.
[32] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[33] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[34] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[35] Qingguo Wang,et al. Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives , 2013, BMC Bioinformatics.
[36] Yangho Chen,et al. Supplementary Methods , 2012, Acta Neuropsychiatrica.
[37] Jack Cuzick,et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.
[38] Klaus Pantel,et al. Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.
[39] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.
[40] E. Perez,et al. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response. , 2009, The Lancet. Oncology.
[41] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[42] C. Klein. Single cell amplification methods for the study of cancer and cellular ageing , 2005, Mechanisms of Ageing and Development.
[43] Joe W. Gray,et al. Genome Amplification of Chromosome 20 in Breast Cancer , 2003, Breast Cancer Research and Treatment.
[44] M. Speicher,et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] P. Meltzer,et al. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. , 1996, Cancer research.
[46] H. Iyer,et al. Regression Analysis-Concepts and Applications , 1995 .
[47] L. Lin,et al. A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.
[48] D. Bates,et al. Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .
[49] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[50] M. Olivé,et al. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.
[51] Data Mining And Knowledge Discovery Handbook , 2022 .
[52] R. Piñeiro,et al. Relevance of CTC Clusters in Breast Cancer Metastasis. , 2020, Advances in experimental medicine and biology.
[53] Hushan Yang,et al. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer , 2016, Breast Cancer Research and Treatment.
[54] Diana Miglioretti,et al. Cell-free DNA Analysis for Noninvasive Examination of Trisomy. , 2015, The New England journal of medicine.